Adding Daratumumab to RVd Improves MRD Negativity, PFS in Newly Diagnosed Myeloma

Press/Media

Period	5 Jun 2022

Media coverage

Title	Adding Daratumumab to RVd Improves MRD Negativity, PFS in Newly Diagnosed Myeloma
Media name/outlet	Cancernetwork.com
Country/Territory	United States
Date	5/06/22
URL	https://www.cancernetwork.com/view/adding-daratumumab-to-rvd-improves-mrd-negativity-pfs-in-newly-diagnosed-myeloma
Persons	Cesar Rodriguez